These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 24359935

  • 1. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia.
    Brain C, Sameby B, Allerby K, Lindström E, Eberhard J, Burns T, Waern M.
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):215-22. PubMed ID: 24359935
    [Abstract] [Full Text] [Related]

  • 2. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
    Brain C, Allerby K, Sameby B, Quinlan P, Joas E, Karilampi U, Lindström E, Eberhard J, Burns T, Waern M.
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
    [Abstract] [Full Text] [Related]

  • 3. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
    Yang J, Ko YH, Paik JW, Lee MS, Han C, Joe SH, Jung IK, Jung HG, Kim SH.
    Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M, Togo T, Yoshimi A, Fujita J, Nomoto M, Kamijo A, Amagai T, Uchikado H, Katsuse O, Hosojima H, Sakura Y, Furusho R, Suda A, Yamaguchi T, Hori T, Kamada A, Kondo T, Ito M, Odawara T, Hirayasu Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):755-60. PubMed ID: 18226436
    [Abstract] [Full Text] [Related]

  • 8. Stigma, discrimination and medication adherence in schizophrenia: results from the Swedish COAST study.
    Brain C, Sameby B, Allerby K, Quinlan P, Joas E, Lindström E, Burns T, Waern M.
    Psychiatry Res; 2014 Dec 30; 220(3):811-7. PubMed ID: 25457284
    [Abstract] [Full Text] [Related]

  • 9. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ, Nakonezny PA, Rush AJ.
    Schizophr Res; 2008 Mar 30; 100(1-3):60-9. PubMed ID: 18255269
    [Abstract] [Full Text] [Related]

  • 10. Relationships among subjective and objective measures of adherence to oral antipsychotic medications.
    Velligan DI, Wang M, Diamond P, Glahn DC, Castillo D, Bendle S, Lam YW, Ereshefsky L, Miller AL.
    Psychiatr Serv; 2007 Sep 30; 58(9):1187-92. PubMed ID: 17766564
    [Abstract] [Full Text] [Related]

  • 11. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T, Liraud F, Verdoux H.
    Encephale; 2003 Sep 30; 29(5):430-7. PubMed ID: 14615692
    [Abstract] [Full Text] [Related]

  • 12. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia.
    Remington G, Kwon J, Collins A, Laporte D, Mann S, Christensen B.
    Schizophr Res; 2007 Feb 30; 90(1-3):229-37. PubMed ID: 17208414
    [Abstract] [Full Text] [Related]

  • 13. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia.
    Byerly MJ, Thompson A, Carmody T, Bugno R, Erwin T, Kashner M, Rush AJ.
    Psychiatr Serv; 2007 Jun 30; 58(6):844-7. PubMed ID: 17535946
    [Abstract] [Full Text] [Related]

  • 14. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D, Delgado A, Bouju S, Comet D, Chiariny JF.
    Encephale; 2013 May 30; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [Abstract] [Full Text] [Related]

  • 15. Accuracy of Clinician Assessments of Medication Status in the Emergency Setting: A Comparison of Clinician Assessment of Antipsychotic Usage and Plasma Level Determination.
    Lopez LV, Shaikh A, Merson J, Greenberg J, Suckow RF, Kane JM.
    J Clin Psychopharmacol; 2017 Jun 30; 37(3):310-314. PubMed ID: 28353490
    [Abstract] [Full Text] [Related]

  • 16. Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics.
    Nakonezny PA, Byerly MJ.
    Schizophr Res; 2006 Feb 15; 82(1):107-14. PubMed ID: 16376522
    [Abstract] [Full Text] [Related]

  • 17. Should full adherence be a necessary goal in schizophrenia? Full versus non-full adherence to antipsychotic treatment.
    Acosta FJ, Ramallo-Fariña Y, Siris SG.
    Compr Psychiatry; 2014 Jan 15; 55(1):33-9. PubMed ID: 24183886
    [Abstract] [Full Text] [Related]

  • 18. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C, Kikkert M, Mazzi MA, Becker T, Bindman J, Schene A, Nosè M, Helm H, Thornicroft G, Tansella M.
    Psychopathology; 2009 Jan 15; 42(5):311-7. PubMed ID: 19672133
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V, Levine SZ, Roe D, Shnitt D, Weizman A, Poyurovsky M.
    Schizophr Res; 2011 Aug 15; 130(1-3):176-81. PubMed ID: 21636254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.